Additional Effects of Sternocleidomastoid Release With SNAGS in the Management of Cervicogenic Headache
NCT ID: NCT06534606
Last Updated: 2024-08-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
38 participants
INTERVENTIONAL
2024-06-10
2024-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Immediate Effects of Suboccipital Muscle Release Combined With Sustained Natural Apophyseal Glides in Patients With Chronic Tension Type Headache
NCT05883813
Effects Of Dry Needling On Sternocleidomastoid Muscle For Pain And Disability In Migraine
NCT05285852
Tension Type Headache, Myofascial Release Therapy , Post Isometric Relaxation Technique
NCT05686811
Spinal Mobilization Versus Myofacial Release Techniques On Pain And Disability In Patients With Tension Type Headache
NCT05673330
Instrument Based Fascial Abrasion Versus Myofascial Release Technique in Cervicogenic Headache Patients
NCT05249647
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conventional physical therapy Group
Both Group A and Group B will receive this conventional physical therapy protocol for cervicogenic headache.
* Moist heat therapy: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.
* TENS application: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.
In addition to this, they will receive Headache SNAGs (Sustained Natural Apophyseal Glides) 5 sets of 10 repetitions. Each repetition will be given with a 10 second hold.
• Frequency: 3 times a week for 2 weeks. 6 sessions in total.
Electrotherapy and physical agents
Moist heat therapy: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.
• TENS application: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.
Headache SNAGs
Headache SNAGs (Sustained Natural Apophyseal Glides) 5 sets of 10 repetitions. Each repetition will be given with a 10 second hold.
• Frequency: 3 times a week for 2 weeks. 6 sessions in total.
Conventional physical therapy with sternocleidomastoid release
Both Group A and Group B will receive this conventional physical therapy protocol for cervicogenic headache.
* Moist heat therapy: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.
* TENS application: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.
Headache SNAGs: In addition to the conventional physical therapy protocol, they will receive Headache SNAGs (Sustained Natural Apophyseal Glides) 5 sets of 10 repetitions. Each repetition will be given with a 10 second hold.
* Frequency: 3 times a week for 2 weeks. 6 sessions in total. Sternocleidomastoid Release: Group B will also receive Sternocleidomastoid release in addition with headache SNAGs. Release to the sternocleidomastoid muscle will be given once per session for 5-8 minutes.
* Frequency: 3 times a week for 2 weeks. 6 sessions in total.
Electrotherapy and physical agents
Moist heat therapy: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.
• TENS application: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.
Headache SNAGs
Headache SNAGs (Sustained Natural Apophyseal Glides) 5 sets of 10 repetitions. Each repetition will be given with a 10 second hold.
• Frequency: 3 times a week for 2 weeks. 6 sessions in total.
Sternocleidomastoid Release
Sternocleidomastoid Release: Group B will also receive Sternocleidomastoid release in addition with headache SNAGs. Release to the sternocleidomastoid muscle will be given once per session for 5-8 minutes.Frequency: 3 times a week for 2 weeks. 6 sessions in total.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Electrotherapy and physical agents
Moist heat therapy: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.
• TENS application: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.
Headache SNAGs
Headache SNAGs (Sustained Natural Apophyseal Glides) 5 sets of 10 repetitions. Each repetition will be given with a 10 second hold.
• Frequency: 3 times a week for 2 weeks. 6 sessions in total.
Sternocleidomastoid Release
Sternocleidomastoid Release: Group B will also receive Sternocleidomastoid release in addition with headache SNAGs. Release to the sternocleidomastoid muscle will be given once per session for 5-8 minutes.Frequency: 3 times a week for 2 weeks. 6 sessions in total.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both males and females
* Unilateral headache with no shift of side
* C1-C2 Dysfunction
* Positive flexion rotation test (Rotation restriction is greater than 10 degrees)
* Headache at least once a month in the last 3 months
* Headache with at least 4 score in NPRS (Sign and Symptoms of Neck Involvement)
* Headache with restriction of ROM in the neck
* Headache precipitated by:
Sustained neck movements, and awkward head positioning. External Pressure over upper cervical or occipital region
Headache Characteristics:
* Moderate-severe, non-throbbing pain, usually starting in the neck.
* Episodes of varying duration, or: fluctuating, continuous pain
Exclusion Criteria
* Diagnosed Cases of:Cervical spondylosis,Cervical radiculopathy/ nerve root involvement/ disc herniation,Cervical instability/ fracture,Vertebrobasilar insufficiency ,Cervical spine surgery,Cervical spondylolisthesis,Spinal infection or tumors,Osteoporosis,History of trauma,Rheumatoid Arthritis,Inflammatory Arthritis
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Foundation University Islamabad
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Foundation University College of Physical Therapy
Rawalpindi, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FUI/CTR/2024/17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.